Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan581명의 회복기 혈장 기증자 중 코로나 바이러스 질병에 따른 높은 항체가와 관련된 요인: 일본의 단일 센터 단면 연구Article Published on 2022-02-012022-09-12 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome antibody Antibody titer Blood candidate chemiluminescence convalescent plasma coronavirus coronavirus disease COVID-19 criteria cross-sectional Donor donors enzyme Factor Fever identify IgG IgG antibody immunoassay Immunoglobulin increasing age independent variables Infection information Japan Japanese Linear regression analysis Multiple Participants Patient patients predict S-protein SARS-CoV-2 SARS-COV-2 infection Screening Screening criteria. selected single-center symptom onset systemic corticosteroid treated Volunteer were measured [DOI] 10.1016/j.jiac.2021.10.012 PMC 바로가기 [Article Type] Article
Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndromeCOVID-19 급성 호흡 곤란 증후군에서 인간 항-LIGHT 단일클론 항체의 무작위, 이중 맹검, 대조 시험Clinical Trial Published on 2022-02-012022-09-12 Journal: The Journal of Clinical Investigation [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] acute respiratory distress acute respiratory distress syndrome Adaptive immunity adults hospitalized adverse event age antibody ARDS benefit clinical trials Controlled trial coronavirus disease Coronavirus disease 2019 Corticosteroids COVID-19 cytokine cytokine-release syndrome Cytokines death double-blind dysregulated immune response elevated enrolled glycoprotein herpesvirus less Mild mild to moderate moderate monoclonal antibody mortality rates multicenter Older Patient patients Placebo Pneumonia primary endpoint proportion Protein Randomized receiving reduce remained Remdesivir Respiration respiratory distress Respiratory failure risk Safety Serum level severe coronavirus disease single dose Standard of care Standard-of-care syndrome systemic corticosteroid systemic corticosteroids T cell T cells Therapeutics therapy TNFSF14 Treatment treatment-emergent adverse events Trial Trial registration [DOI] 10.1172/JCI153173 PMC 바로가기 [Article Type] Clinical Trial
Interleukin-37: A Link Between COVID-19, Diabetes, and the Black FungusMicrobiology Published on 2022-01-132022-10-31 Journal: Frontiers in Microbiology [Category] COVID-19, [키워드] black Comorbidity coronavirus disease Corticosteroids COVID-19 COVID-19 pandemic COVID-19 patients cytokine diabete diabetes Diabetic dysregulated immune response Fungal infection fungus hospitals IL-1 IL-37 immune responses Infection Inflammation Initiation invasive involved lack lower mortality Mucormycosis oxygen Patient reduce reducing secondary infections severe COVID-19 systemic corticosteroid T2D use of corticosteroid [DOI] 10.3389/fmicb.2021.788741 PMC 바로가기 [Article Type] Microbiology
Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admissionObservational Study Published on 2022-01-012022-10-05 Journal: Journal of medical virology [Category] 임상, [키워드] acute phase administer Administered Admission analyzed attenuate chest pain Clinical data Cognitive impairment collected Corticosteroid Corticosteroids COVID-19 COVID-19 symptom Depression died domain Dysphagia Evolution excluded headache hospital IMPROVE infection with SARS-CoV-2 less Long COVID MOST Observational cohort study Other outcome Patient patients persistence Post-acute COVID-19 syndrome Quality of life questionnaire receive SARS-CoV-2 significantly statistically significant difference Symptom systemic corticosteroid the disease took place Treatment variable [DOI] 10.1002/jmv.27296 PMC 바로가기 [Article Type] Observational Study
Long-Term Follow-Up of a Severe Eosinophilic Asthmatic Patient With Comorbid Nasal Polyposis Hospitalized for SARS-CoV-2 Infection While Receiving Benralizumab: A Case ReportEmergency Medicine Published on 2021-12-122022-10-31 Journal: Cureus [Category] COVID-19, [키워드] "anti il5-r" acute respiratory syndrome administration affected Asthma bursts Chest complications coronavirus coronavirus disease Corticosteroid COVID-19 symptoms covid-19|||severe eosinophilic asthma|||nasal polyps|||benralizumab|||interstitial pneumonia discharge discharged emergency medical service emergency visit|||spirometry|||biologic|||long term follow up Eosinophilic Hospitalized Infection interstitial pneumonia long term follow up Long-term follow-up low-flow oxygen therapy Lung function nasal Patient Polyposis regimen report SARS-CoV-2 SCS SEA systemic corticosteroid the patient the SARS-CoV-2 therapy Treatment while [DOI] 10.7759/cureus.20364 PMC 바로가기 [Article Type] Emergency Medicine
Anti-Inflammatory Effects of Immunostimulation in Patients with COVID-19 PneumoniaArticle Published on 2021-12-092022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] Admission association Biomarker Blood cell supernatant cellular changes in Characteristics chemokines clinical conditions Control COVID-19 cytokine disease severity Effect gene expression pattern Genetic groups IFN-γ IL-4 immune response immunomodulation immunomodulator immunostimulation in vitro in-hospital mortality Inflammatory Influenza innate response intubation rate investigated molecular Neutrophil-to-lymphocyte ratio NLR not differ outcome outcomes Patient pidotimod plasma plasma concentration Pneumonia RCTs Recognition Respiratory failure SARS-CoV-2 Standard of care Standard-of-care systemic corticosteroid therapy toll like receptor Transcription treated upregulated viral infection Viral pneumonia virus were assessed with COVID-19 [DOI] 10.3390/jcm10245765 PMC 바로가기 [Article Type] Article
Sight-threatening intraocular infection in patients with COVID-19 in India인도의 COVID-19 환자에서 시력을 위협하는 안내 감염Article Published on 2021-12-012022-09-12 Journal: Indian journal of ophthalmology [Category] SARS, 진단, [키워드] Admission age analyzed Antibiotics antiviral drug biopsy caused Comorbidities COVID-19 COVID-19 patient COVID-19-related complication Culture discharge eight endogenous endophthalmitis Epidemiology eye eyes feature fungi hospital Hospitalization Immunosuppressive agents India Infection inhibitor intensive care unit interleukin-6 Intraocular intraocular infection. laboratory-confirmed low molecular weight majority male management microbiologically Microscopy nine ocular ophthalmic outcomes Patient patients patients died patients with COVID-19 PCR positive presenting progressed south India Standard of care supplemental oxygen Symptoms systemic corticosteroid the median Tocilizumab Treatment vitreous [DOI] 10.4103/ijo.IJO_1474_21 PMC 바로가기 [Article Type] Article
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial입원한 성인 COVID-19(COV-BARRIER) 치료를 위한 바리시티닙의 효능 및 안전성: 무작위, 이중 맹검, 병행군, 위약 대조 3상 시험Clinical Trial Published on 2021-12-012022-09-11 Journal: The Lancet. Respiratory Medicine [Category] Fulltext, SARS, 임상, 치료법, 치료제, [키워드] 1:1 95% CI Abstract addition all-cause mortality anti-inflammatory properties antivirals Asia assigned available data Baricitinib baseline Care Combination company Corticosteroids country death defined Dexamethasone Disease progression dose double-blind Efficacy and safety enrolled Europe evaluate event exploratory Follow-up French frequencies Frequency hazard ratio High-flow oxygen hospitalised inhibitor intention-to-treat population Invasive mechanical ventilation Janus kinase Japanese Lilly material Mortality non-invasive ventilation North America Odds ratio oxygen parallel-group participant Participants Phase 3 phase 3 trial Placebo placebo group placebo-controlled placebo-controlled trial prevented primary endpoint progressed proportion randomised Randomly receive receiving reduced reduction in Registered Remdesivir risk risk difference safety analyses safety analysis safety population safety profile secondary endpoint selective Serious Adverse Event Serious Adverse Events serious infection serious infections South America Spanish Standard Standard of care study drug systemic corticosteroid systemic corticosteroids the placebo group the primary endpoint thromboembolic translation Treatment two groups venous thromboembolic were assessed with COVID-19 [DOI] 10.1016/S2213-2600(21)00331-3 PMC 바로가기 [Article Type] Clinical Trial
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel DiseaseResearch Article Published on 2021-11-302022-11-01 Journal: Canadian journal of gastroenterology & hepatology [Category] COVID-19, MERS, SARS, [키워드] age analyzed Biologic therapy Biomarkers Canada clinical clinical activity Cohort Comorbidities Comorbidity COVID-19 COVID-19 in patient COVID-19 infection COVID-19 vaccination COVID-19 vaccinations death diagnosed with COVID-19 died disease evaluate Factor female General population Hospitalization IBD immunosuppressive Impact increased risk Infection Inflammatory bowel disease initial IQR McGill University median Mortality occurred Odds ratio outcome outcomes Patient patients Pneumonia Prevalence prevalence of COVID-19 proportion reported Result risk factor severe COVID-19 Severe COVID-19 Infection significantly lower systemic corticosteroid therapy was obtained [DOI] 10.1155/2021/7591141 PMC 바로가기 [Article Type] Research Article
Rhino-orbital-cerebral mucormycosis: fungal epidemic in a viral pandemicRhino-orbital-cerebral mucormycosis: 바이러스 전염병의 곰팡이 전염병Article Published on 2021-11-012022-09-11 Journal: The Journal of laryngology and otology [Category] SARS, 치료기술, [키워드] age Amphotericin amphotericin B antifungal therapy Care clinical feature Clinical features Co-infection co-morbidities conducted coronavirus coronavirus disease Coronavirus disease 2019 Corticosteroids COVID-19 diabetes Diabetes Mellitus diagnosed Early detection endonasal Epidemic facial female fungal high-risk patient High-risk patients Immunosuppression IMPROVE Infection male morbidities Mucormycosis Necrosis ophthalmic orbital exenteration palatal pandemic Patient patients survival Symptom systemic corticosteroid systemic corticosteroids total maxillectomy was performed [DOI] 10.1017/S0022215121002309 PMC 바로가기 [Article Type] Article